GSK lets Netherlands cut flu vax order; Mylan seeks OK to copy Pfizer's Sutent;

 @FiercePharma: FDA picks up the pace with warning letters. Article | Follow @FiercePharma

> GlaxoSmithKline has agreed to reduce a contract for the supply of H1N1 flu vaccines to the Dutch government, cutting the order by 30 percent and saving the Netherlands 21 million euros. Report

> Mylan has applied for U.S. regulatory approval to sell a generic version of Pfizer's Sutent cancer pill by challenging several patents on the drug. Report

> India's cancer-drug market, valued at about $271 million, will grow 16 percent annually for the next five years, driven by increased demand for the latest tumor-fighting therapies, Datamonitor Group said. Report

> India's Dr. Reddy's Laboratories won FDA approval to launch its version of Astellas Pharma's Prograf, used to help prevent rejection of kidney and liver transplants. Report

> Cumberland Pharmaceuticals reported that its first-quarter net income decreased to $324,000 from $1.22 million prior year. Report

> Medical safety product maker Unilife said that former Wyeth executive Mary Kate Wold has joined its board of directors. Report

Biotech News

 @FierceBiotech: Big Pharma tries to think like a biotech while reengineering R&D.  Report | Follow @FierceBiotech

  @JohnCFierce: Big Pharma knows it has a huge development problem, but I don't buy the we'll-act-like-biotechs-from-now-on routine. Report | Follow @JohnCFierce

> Wall Street to keep eye on Vertex data. Story

> Inhibitex starts trial for oral Hep C drug. News

> Seattle BioMed initiates malaria vax trial. Report

> GenVec gets another NASDAQ warning. Item

> Ikaria plots $200M IPO. Article

> OSI shares rise as bid deadline nears. Report

And Finally... A "scratch-and-win" war is being waged on Africa's fake malaria medicines. Report